Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


25.03.2024

3 Diabetes
1 Intern Med
1 J Autoimmun
3 J Clin Endocrinol Metab
2 J Immunol
1 J Nephrol
1 J Neuroimmunol
2 J Neurol
1 J Rheumatol
3 Mult Scler
2 N Engl J Med
2 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Diabetes

  1. EVANS-MOLINA C
    The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
    Diabetes. 2024;73:545-553.
    PubMed         Abstract available

  2. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
    DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
    Diabetes. 2024;73:554-564.
    PubMed         Abstract available

  3. LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al
    Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in patients with type 1 diabetes.
    Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277.
    PubMed         Abstract available


    Intern Med

  4. KIRITO K
    Silent Thyroiditis Associated with Ropeginterferon alpha-2b in a Patient with Polycythemia Vera.
    Intern Med. 2024;63:843-846.
    PubMed         Abstract available


    J Autoimmun

  5. WANG Y, Wang S, Liu W, Gu H, et al
    Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
    J Autoimmun. 2024;145:103205.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  6. UHL S, Choure A, Rouse B, Loblack A, et al
    Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2023 Nov 21:dgad652. doi: 10.1210.
    PubMed         Abstract available

  7. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
    Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
    J Clin Endocrinol Metab. 2024;109:1071-1079.
    PubMed         Abstract available

  8. BROWN N, Elston MS
    Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin.
    J Clin Endocrinol Metab. 2024;109:936-943.
    PubMed         Abstract available


    J Immunol

  9. WU J, Han K, Sack MN
    Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation.
    J Immunol. 2024;212:1043-1050.
    PubMed         Abstract available

  10. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    PubMed         Abstract available


    J Nephrol

  11. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    PubMed         Abstract available


    J Neuroimmunol

  12. CHANG EH, Hardy TA
    Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series.
    J Neuroimmunol. 2024;389:578330.
    PubMed         Abstract available


    J Neurol

  13. ALBERGONI M, Pagani E, Preziosa P, Meani A, et al
    Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis.
    J Neurol. 2024 Mar 20. doi: 10.1007/s00415-024-12277.
    PubMed         Abstract available

  14. ABDELGAIED MY, Rashad MH, El-Tayebi HM, Solayman MH, et al
    Correction to: The impact of metformin use on the outcomes of relapse?remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open?label randomized controlled trial.
    J Neurol. 2024 Mar 18. doi: 10.1007/s00415-024-12249.
    PubMed        


    J Rheumatol

  15. YAMAMOTO H, Taniguchi Y
    Cranial Giant Cell Arteritis and Subdural Hematoma.
    J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
    PubMed         Abstract available


    Mult Scler

  16. CAMPAGNA MP, Havrdova EK, Horakova D, Izquierdo G, et al
    No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
    Mult Scler. 2024 Mar 21:13524585241240406. doi: 10.1177/13524585241240406.
    PubMed         Abstract available

  17. HJALGRIM H, Rostgaard K
    Infectious mononucleosis and risk of multiple sclerosis: Proxy or culprit?
    Mult Scler. 2024 Mar 21:13524585241237708. doi: 10.1177/13524585241237708.
    PubMed        

  18. GOLDACRE R
    Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
    Mult Scler. 2024 Mar 21:13524585241237707. doi: 10.1177/13524585241237707.
    PubMed         Abstract available


    N Engl J Med

  19. NETEA MG, van de Veerdonk FL
    Anti-Interleukin-23 Autoantibodies and Severe Infections.
    N Engl J Med. 2024;390:1143-1146.
    PubMed        

  20. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
    Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    N Engl J Med. 2024;390:1105-1117.
    PubMed         Abstract available


    Neurology

  21. AGYEI P, Chen M, Guo Y, Perez CA, et al
    Pearls & Oy-sters: KLHL11 IgG Paraneoplastic-Associated Hearing Loss and Rhombencephalitis in a Woman With Metastatic Mullerian Tumor.
    Neurology. 2024;102:e209187.
    PubMed         Abstract available

  22. ZOUVELOU V, Petrou EM, Strataki E, Vasileiou V, et al
    Pearls & Oy-sters: Thyroid-Associated Ophthalmopathy and Transient Neuromuscular Junction Disorder Due to Graves Disease.
    Neurology. 2024;102:e209282.
    PubMed         Abstract available


    PLoS One

  23. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.